Vera Therapeutics Trutakna priced at $425,000 per year - conf call ($42.96, 0.00)
StreetAccount Summary - Private Company Weekly Recap - Week of 29-Jun
StreetAccount Summary - Private company transactions for the week ended 04-Jul
Media, autos/parts, financials and travel outperform; utilities, energy, telecom and tech lag:
Novartis downgraded to hold from buy at Vontobel (CHF 127.92, 0.00)
Powered by FactSet Research Systems Inc.